Skip to Content
Medical Term:

brentuximab vedotin


An antineoplastic agent used in CD30-positive neoplasms consisting of a chimeric monoclonal antibody directed against CD30 linked to the antimitotic toxic agent monomethyl auristatin E via a cleavable linker.

© Copyright 2017 Wolters Kluwer. All Rights Reserved. Review Date: Sep 19, 2016.